SHP2 Antibody

About the Target

SHP2 (Src homology 2 domain-containing phosphatase 2), encoded by the PTPN11 gene, is a cytoplasmic non-receptor protein tyrosine phosphatase vital for transmitting signals from growth factor, cytokine, and integrin receptors to intracellular cascades. It contains two N-terminal SH2 domains (N-SH2 and C-SH2), a central catalytic PTP domain, and a C-terminal tail with phosphorylation motifs. Depending on the literature source, SHP2 may also be discussed as PTP2C and SHPTP2.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following SHP2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SHP2 is commonly interpreted in the context of cancer, immunology, and developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• context differences tied to immune-cell state, activation, or lineage composition
• stage-dependent patterns during differentiation, morphogenesis, or lineage commitment

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SHP2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SHP2 reflect biology rather than handling. When interpreting SHP2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SHP2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.